Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | PPARG | P37231 | 2/20 | 0.35 |
| ▸ | PPARD | Q03181 | 2/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | XDH | P47989 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5598779 | 0.80 | GSR (0.53) | ALDH1A1PPARGPPARDCYP3A4XDH | |
| SCHEMBL5599075 | 0.77 | ALDH1A1 (0.44) | ALDH1A1PPARGPPARDPPARACYP3A4 | |
| SCHEMBL840617 | 0.76 | GABRA1 (0.38) | GABRA1GABRB2GAAMAPTGSR | |
| SCHEMBL101727 | 0.76 | DHFR (0.41) | ALDH1A1CYP3A4TSHRGABRA1GABRB2 | |
| SCHEMBL9327649 | 0.74 | ALDH1A1 (0.42) | ALDH1A1PPARGPPARDPPARACYP3A4 | |
| SCHEMBL4950189 | 0.74 | ALDH1A1 (0.32) | ALDH1A1PPARGPPARDPPARACYP3A4 | |
| SCHEMBL11297222 | 0.74 | GSR (0.36) | GAAGSRPTGS2 | |
| SCHEMBL20930073 | 0.74 | GSR (0.36) | GABRA1GABRB2GAAMAPTGSR | |
| Hydrochloric Acid SCHEMBL15287283 | 0.74 | DHFR (0.40) | GABRA1GABRB2GAAMAPTGSR | |
| SCHEMBL9774970 | 0.72 | ALDH1A1 (0.38) | ALDH1A1PPARGPPARDPPARACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7319083-B2 | Polymerized catalyst composition | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-01-15 | — | — | US | disclosed |
| US-7176158-B2 | Polymerization catalyst composition | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-02-13 | — | — | US | disclosed |
| US-7119155-B2 | Polymerized catalyst composition II | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-10-10 | — | — | US | disclosed |
| US-20040157728-A1 | For polymerizing or oligomerizing one or more olefins | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-08-12 | — | — | US | disclosed |
| US-20040147771-A1 | Polymerization catalyst composition | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-07-29 | — | — | US | disclosed |
| US-20040147391-A1 | Polymerized catalyst composition II | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147771-A1 | Polymerization catalyst composition | POLN, ACE2, ACE | ALDH1A1 1051/4885PPARG 3426/4885PPARD 3586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.